A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Conditions
Colorectal Cancer · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA ( Site 0317), Los Angeles, California, United States
University of Colorado Anschutz Medical Campus ( Site 0299), Aurora, Colorado, United States
University of Colorado Anschutz Medical Campus ( Site 0325), Aurora, Colorado, United States
University of Colorado Anschutz Medical Campus ( Site 0326), Aurora, Colorado, United States
Sibley Memorial Hospital ( Site 0310), Washington D.C., District of Columbia, United States
University of Florida College of Medicine ( Site 0281), Gainesville, Florida, United States
Mount Sinai Cancer Center ( Site 0287), Miami Beach, Florida, United States
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0303), Marietta, Georgia, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola, New York, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0324), New York, New York, United States
University of Texas MD Anderson Cancer Center ( Site 0316), Houston, Texas, United States
Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke, Virginia, United States
University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0293), Madison, Wisconsin, United States
Westmead Hospital ( Site 0003), Westmead, New South Wales, Australia
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 0001), Brisbane, Queensland, Australia
Epworth Freemasons ( Site 0005), East Melbourne, Victoria, Australia
Frankston Hospital-Oncology and Haematology ( Site 0004), Frankston, Victoria, Australia
One Clinical Research ( Site 0002), Nedlands, Western Australia, Australia
The Ottawa Hospital Cancer Centre ( Site 0027), Ottawa, Ontario, Canada
Centre Hospitalier de l'Université de Montréal-Unit for Innovative Therapies ( Site 0022), Montreal, Quebec, Canada
McGill University Health Centre ( Site 0023), Montreal, Quebec, Canada
James Lind Centro de Investigacion del Cancer ( Site 0048), Temuco, Araucania, Chile
FALP-UIDO ( Site 0041), Providencia, Region M. de Santiago, Chile
Clínica UC San Carlos de Apoquindo ( Site 0043), Santiago, Region M. de Santiago, Chile
Bradfordhill-Clinical Area ( Site 0047), Santiago, Region M. de Santiago, Chile
Beijing Cancer hospital-Digestive Oncology ( Site 0061), Beijing, Beijing Municipality, China
The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army ( Site 0063), Fuzhou, Fujian, China
Wuhan Union Hospital Cancer Center. ( Site 0064), Wuhan, Hubei, China
Hunan Cancer Hospital-intervention department ( Site 0066), Changsha, Hunan, China
Renji Hospital Shanghai Jiao Tong University School of Medicine-Oncology Department ( Site 0067), Shanghai, Shanghai Municipality, China
West China Hospital, Sichuan University ( Site 0068), Chengdu, Sichuan, China
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0101), Milan, Lombardy, Italy
ASST Grande Ospedale Metropolitano Niguarda ( Site 0102), Milan, Lombardy, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 0103), Roma, Italy
National Cancer Center Hospital East ( Site 0121), Kashiwa, Chiba, Japan
Kanagawa Cancer Center ( Site 0122), Yokohama, Kanagawa, Japan
Seoul National University Hospital ( Site 0161), Seoul, South Korea
Severance Hospital, Yonsei University Health System ( Site 0164), Seoul, South Korea
Asan Medical Center ( Site 0163), Seoul, South Korea
Samsung Medical Center ( Site 0162), Seoul, South Korea
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 0183), Madrid, Madrid, Comunidad de, Spain
Hospital Universitario Central de Asturias-Medical Oncology ( Site 0182), Oviedo, Principality of Asturias, Spain
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 0181), Barcelona, Spain
Hôpitaux Universitaires de Genève (HUG) ( Site 0202), Geneva, Canton of Geneva, Switzerland
Ospedale Regionale Bellinzona e Valli ( Site 0201), Bellinzona, Canton Ticino, Switzerland
China Medical University Hospital ( Site 0223), Taichung, Taiwan
National Cheng Kung University Hospital-Clinical Trial Center ( Site 0224), Tainan, Taiwan
National Taiwan University Hospital-Oncology ( Site 0225), Taipei, Taiwan
Taipei Veterans General Hospital ( Site 0221), Taipei, Taiwan
Chang Gung Medical Foundation-Linkou Branch ( Site 0222), Taoyuan, Taiwan
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0241), Ankara, Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 0242), Ankara, Turkey (Türkiye)
Barts Health NHS Trust ( Site 0263), London, England, United Kingdom
Royal Free Hospital ( Site 0262), London, England, United Kingdom
University Hospital Coventry & Warwickshire ( Site 0266), Coventry, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC